NCT04275245View on ClinicalTrials.gov

Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

March 9, 2020

Study Completion Date

March 9, 2020

Conditions
Coronavirus Disease 2019 (COVID-19)
Interventions
DRUG

Meplazumab for Injection

humanized MAb against CD147

Trial Locations (1)

710032

Tangdu Hospital, Xi'an

All Listed Sponsors
lead

Tang-Du Hospital

OTHER

NCT04275245 - Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia | Biotech Hunter | Biotech Hunter